OraSure Technologies (OSUR) Competitors $3.10 +0.05 (+1.64%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$3.04 -0.06 (-1.77%) As of 07/11/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock OSUR vs. STAA, CERS, UTMD, ANIK, WST, COO, ALGN, MMSI, HAE, and ICUIShould you be buying OraSure Technologies stock or one of its competitors? The main competitors of OraSure Technologies include STAAR Surgical (STAA), Cerus (CERS), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), West Pharmaceutical Services (WST), Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), Haemonetics (HAE), and ICU Medical (ICUI). These companies are all part of the "health care supplies" industry. OraSure Technologies vs. Its Competitors STAAR Surgical Cerus Utah Medical Products Anika Therapeutics West Pharmaceutical Services Cooper Companies Align Technology Merit Medical Systems Haemonetics ICU Medical OraSure Technologies (NASDAQ:OSUR) and STAAR Surgical (NASDAQ:STAA) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and risk. Do analysts recommend OSUR or STAA? OraSure Technologies currently has a consensus target price of $3.00, indicating a potential downside of 3.23%. STAAR Surgical has a consensus target price of $24.63, indicating a potential upside of 41.69%. Given STAAR Surgical's higher possible upside, analysts clearly believe STAAR Surgical is more favorable than OraSure Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OraSure Technologies 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00STAAR Surgical 1 Sell rating(s) 9 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media favor OSUR or STAA? In the previous week, OraSure Technologies had 1 more articles in the media than STAAR Surgical. MarketBeat recorded 6 mentions for OraSure Technologies and 5 mentions for STAAR Surgical. STAAR Surgical's average media sentiment score of 1.17 beat OraSure Technologies' score of 0.73 indicating that STAAR Surgical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OraSure Technologies 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive STAAR Surgical 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, OSUR or STAA? OraSure Technologies has a beta of 0.45, meaning that its stock price is 55% less volatile than the S&P 500. Comparatively, STAAR Surgical has a beta of 0.58, meaning that its stock price is 42% less volatile than the S&P 500. Do insiders & institutionals believe in OSUR or STAA? 93.5% of OraSure Technologies shares are owned by institutional investors. Comparatively, 96.7% of STAAR Surgical shares are owned by institutional investors. 3.9% of OraSure Technologies shares are owned by company insiders. Comparatively, 1.0% of STAAR Surgical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has stronger valuation & earnings, OSUR or STAA? OraSure Technologies has higher earnings, but lower revenue than STAAR Surgical. STAAR Surgical is trading at a lower price-to-earnings ratio than OraSure Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOraSure Technologies$185.83M1.25-$19.50M-$0.42-7.38STAAR Surgical$313.90M2.74-$20.21M-$1.44-12.07 Is OSUR or STAA more profitable? OraSure Technologies has a net margin of -19.77% compared to STAAR Surgical's net margin of -25.46%. OraSure Technologies' return on equity of -5.86% beat STAAR Surgical's return on equity.Company Net Margins Return on Equity Return on Assets OraSure Technologies-19.77% -5.86% -5.20% STAAR Surgical -25.46%-10.59%-8.32% SummaryOraSure Technologies beats STAAR Surgical on 8 of the 15 factors compared between the two stocks. Get OraSure Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for OSUR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OSUR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OSUR vs. The Competition Export to ExcelMetricOraSure TechnologiesMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$228.14M$10.60B$5.60B$9.11BDividend YieldN/A2.07%5.24%4.02%P/E Ratio-7.3816.2727.9620.25Price / Sales1.2530.15430.5799.61Price / Cash78.5622.9637.4658.16Price / Book0.563.668.045.49Net Income-$19.50M$235.43M$3.18B$250.27M7 Day Performance0.65%1.27%3.63%4.75%1 Month Performance5.80%2.95%4.04%7.64%1 Year Performance-27.91%-15.74%29.56%16.34% OraSure Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OSUROraSure Technologies2.5536 of 5 stars$3.10+1.6%$3.00-3.2%-27.8%$228.14M$185.83M-7.38840News CoverageSTAASTAAR Surgical4.0674 of 5 stars$16.78-0.8%$24.63+46.8%-63.3%$837.98M$313.90M0.001,211Positive NewsCERSCerus2.5412 of 5 stars$1.41-0.7%$3.50+148.2%-31.3%$271.45M$180.27M0.00290Positive NewsUTMDUtah Medical Products1.9922 of 5 stars$56.92-1.5%N/A-18.6%$187.75M$40.90M15.29180Positive NewsANIKAnika Therapeutics4.3186 of 5 stars$10.58-1.5%$20.00+89.0%-59.0%$154.03M$119.91M0.00300Positive NewsWSTWest Pharmaceutical Services4.8049 of 5 stars$218.800.0%$320.00+46.3%-31.9%$15.72B$2.89B32.9610,600COOCooper Companies3.1185 of 5 stars$71.16+0.0%$99.70+40.1%-15.6%$14.23B$3.90B18.3316,000Analyst DowngradeALGNAlign Technology4.6277 of 5 stars$189.33+0.4%$241.25+27.4%-21.1%$13.66B$4.00B27.1220,945Positive NewsAnalyst ForecastMMSIMerit Medical Systems4.3208 of 5 stars$93.480.0%$109.11+16.7%+7.1%$5.53B$1.36B26.717,400Positive NewsAnalyst ForecastHAEHaemonetics4.9153 of 5 stars$74.77+1.3%$96.80+29.5%-15.6%$3.55B$1.36B16.153,023News CoverageAnalyst UpgradeAnalyst RevisionICUIICU Medical4.4122 of 5 stars$132.15+0.3%$192.67+45.8%+3.1%$3.24B$2.38B23.9215,000Positive News Related Companies and Tools Related Companies STAAR Surgical Competitors Cerus Competitors Utah Medical Products Competitors Anika Therapeutics Competitors West Pharmaceutical Services Competitors Cooper Companies Competitors Align Technology Competitors Merit Medical Systems Competitors Haemonetics Competitors ICU Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OSUR) was last updated on 7/12/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OraSure Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OraSure Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
